Evidence map›Paper›PMID 34918563›Full record

ArticleTechnology in cancer research & treatment

MicroRNA-133b Inhibits nTumor Cell Proliferation, Migration and Invasion by Targeting SUMO1 in Endometrial Carcinoma.

Lingyun Liao, Yun Chen, Jieli Zhou, Jing Ye

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Advances in MiRNAs Involved in Endometrial Carcinoma.Combinatorial chemistry & high throughput screening · 2025
    Review
  2. Review
  3. Article
  4. Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lingyun Liao477808First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Yun Chen477808First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Jieli Zhou477808First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Jing YeSchool of Clinical Medicine, 74582Jiangxi University of Traditional Chinese Medicine, Nanchang, China.ORCID 0000-0003-2347-8237
First Affiliated Hospital of Gannan Medical University · CNJiangxi University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticRNA InterferenceCell Line, TumorCell MovementCell ProliferationComputational BiologyDatabases, GeneticEndometrial NeoplasmsFemaleGene Expression ProfilingHumansMicroRNAsSUMO-1 ProteinTranscriptomeMicroRNAsMIRN133 microRNA, humanSUMO-1 ProteinSUMO1 protein, humanendometrial carcinomainvasionmigrationmiR-133bproliferationSUMO1

Identifiers

PMID34918563
PMCPMC8721366
OpenAlexW4200017428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.